55:@0.895357:0.033217:0.916054:0.033217:0.916054:0.013052:0.895357:0.013052:0.010348:0.010348
HANDBOOK OF GENERAL MEDICINE VOL 1:@0.649278:0.972666:0.923020:0.972666:0.923020:0.958637:0.649278:0.958637:0.009179:0.009945:0.009945:0.009999:0.007714:0.011679:0.011679:0.007943:0.003723:0.011679:0.006518:0.003723:0.011719:0.007203:0.009945:0.007203:0.008158:0.009945:0.006209:0.003723:0.012351:0.007203:0.009999:0.003037:0.010926:0.003037:0.009945:0.007203:0.003723:0.009434:0.011679:0.006209:0.003723:0.007445
TREATMENT AppROACHEs:@0.983817:0.243404:0.983817:0.056389:0.958557:0.056389:0.958557:0.243404:0.008796:-0.015759:0.000000:0.000000:0.000000:0.000000:0.000000:0.000000:0.114251:0.006043:0.014598:-0.134892:0.158619:-0.158619:0.000000:0.000000:0.000000:0.000000:0.242661:0.009202
TREATMENT AppROACHEs:@0.397039:0.033156:0.624383:0.033156:0.624383:0.013866:0.397039:0.013866:0.007872:0.011217:0.009905:0.013674:0.007872:0.016982:0.009905:0.013674:0.007872:0.005119:0.013674:0.010939:0.010939:0.011217:0.016058:0.013674:0.015023:0.012621:0.009905:0.009202
HyPOtHyrOiDism in PreGnAnCy :@0.076191:0.244004:0.381091:0.244004:0.381091:0.223840:0.076191:0.223840:0.012566:0.011457:0.010348:0.015522:0.007761:0.012566:0.011457:0.010718:0.015522:0.005174:0.012935:0.005174:0.009609:0.016631:0.005174:0.005174:0.013674:0.005174:0.010348:0.010718:0.009609:0.015522:0.013674:0.013674:0.013674:0.014413:0.011457:0.005174
Maternal  hypothyroidism in pregnancy  is associated :@0.076190:0.259945:0.485130:0.259945:0.485130:0.244163:0.076190:0.244163:0.013894:0.010326:0.005125:0.009827:0.004551:0.009223:0.010326:0.003024:0.004188:0.004702:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.008905:0.003024:0.009223:0.008905:0.010311:0.004551:0.009827:0.010175:0.009223:0.010326:0.009223:0.009782:0.008104:0.004188:0.004702:0.003024:0.005866:0.008905:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188
with adverse pregnancy  and foetal  outcomes:@0.076190:0.274112:0.429825:0.274112:0.429825:0.258329:0.076190:0.258329:0.012564:0.003024:0.005125:0.009223:0.007287:0.010326:0.010357:0.008376:0.009827:0.004551:0.005866:0.009827:0.007287:0.010311:0.004551:0.009827:0.010175:0.009223:0.010326:0.009223:0.009782:0.008104:0.004188:0.003084:0.010326:0.009223:0.010357:0.007287:0.004747:0.009903:0.009827:0.005125:0.010326:0.003024:0.004188:0.003084:0.009903:0.009192:0.005125:0.009782:0.009903:0.014182:0.009827:0.005866
7,26 :@0.429815:0.268807:0.449247:0.268807:0.449247:0.259653:0.429815:0.259653:0.004858:0.002429:0.004858:0.004858:0.002429
and :@0.451046:0.274106:0.485139:0.274106:0.485139:0.258323:0.451046:0.258323:0.010326:0.009223:0.010357:0.004188
inadequate thyroxine replacement in early pregnancy :@0.076185:0.288261:0.485139:0.288261:0.485139:0.272478:0.076185:0.272478:0.003024:0.009223:0.010326:0.010357:0.009827:0.010311:0.009192:0.010326:0.005125:0.009827:0.005080:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.005065:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.005080:0.003024:0.009223:0.005080:0.009827:0.010326:0.004551:0.003024:0.008104:0.005080:0.010311:0.004551:0.009827:0.010175:0.009223:0.010326:0.009223:0.009782:0.008104:0.004188
can cause mild reductions in a child’s intellectual abil-:@0.076185:0.302427:0.480952:0.302427:0.480952:0.286644:0.076185:0.286644:0.009782:0.010326:0.009223:0.005201:0.009782:0.010326:0.009192:0.005866:0.009827:0.005201:0.014182:0.003024:0.003024:0.010357:0.005201:0.004551:0.009827:0.010357:0.009192:0.009782:0.005125:0.003024:0.009903:0.009223:0.005866:0.005186:0.003024:0.009223:0.005201:0.010326:0.005201:0.009782:0.009223:0.003024:0.003024:0.010357:0.005307:0.005866:0.005201:0.003024:0.009223:0.005125:0.009827:0.003024:0.003024:0.009827:0.009782:0.005125:0.009192:0.010326:0.003024:0.005201:0.010326:0.010311:0.003024:0.003054:0.005020
ity. Women need more thyroid hormone  during preg-:@0.076185:0.316582:0.480952:0.316582:0.480952:0.300799:0.076185:0.300799:0.003024:0.005125:0.008104:0.004188:0.006501:0.014514:0.009903:0.014182:0.009827:0.009223:0.006501:0.009223:0.009827:0.009827:0.010357:0.006501:0.014182:0.009903:0.004551:0.009827:0.006501:0.005125:0.009223:0.008104:0.004551:0.009888:0.003024:0.010357:0.006501:0.009223:0.009903:0.004551:0.014182:0.009903:0.009223:0.009827:0.004188:0.002298:0.010357:0.009192:0.004551:0.003024:0.009223:0.010175:0.006501:0.010311:0.004551:0.009827:0.010175:0.005020
nancy and should be advised to increase thyroxine dos-:@0.076185:0.330748:0.480952:0.330748:0.480952:0.314965:0.076185:0.314965:0.009223:0.010326:0.009223:0.009782:0.008104:0.003447:0.010326:0.009223:0.010357:0.003447:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.003447:0.010311:0.009827:0.003447:0.010326:0.010357:0.008376:0.003024:0.005866:0.009827:0.010357:0.003447:0.005125:0.009903:0.003432:0.003024:0.009223:0.009782:0.004551:0.009827:0.010326:0.005866:0.009827:0.003432:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.003432:0.010357:0.009903:0.005866:0.005020
age by around 30% as soon as they are pregnant. The :@0.076185:0.344903:0.485155:0.344903:0.485155:0.329120:0.076185:0.329120:0.010326:0.010175:0.009827:0.005125:0.010311:0.008104:0.005140:0.010326:0.004551:0.009903:0.009192:0.009223:0.010357:0.005125:0.008376:0.008376:0.011717:0.005140:0.010326:0.005866:0.005140:0.005866:0.009903:0.009903:0.009223:0.005125:0.010326:0.005866:0.005140:0.005125:0.009223:0.009827:0.008104:0.005125:0.010326:0.004551:0.009827:0.005125:0.010311:0.004551:0.009827:0.010175:0.009223:0.010326:0.009223:0.005125:0.004188:0.005125:0.006441:0.009223:0.009827:0.004188
thyroxine dosage should be reduced to pre-pregnancy :@0.076185:0.359069:0.485139:0.359069:0.485139:0.343286:0.076185:0.343286:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.004037:0.010357:0.009903:0.005866:0.010326:0.010175:0.009827:0.004037:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004037:0.010311:0.009827:0.004037:0.004551:0.009827:0.010357:0.009192:0.009782:0.009827:0.010357:0.004037:0.005125:0.009903:0.004037:0.010311:0.004551:0.009827:0.005020:0.010311:0.004551:0.009827:0.010175:0.009223:0.010326:0.009223:0.009782:0.008104:0.004188
levels within four weeks of delivery.:@0.076185:0.373224:0.329247:0.373224:0.329247:0.357441:0.076185:0.357441:0.003024:0.009827:0.008376:0.009827:0.003024:0.005866:0.004188:0.012564:0.003024:0.005125:0.009223:0.003024:0.009223:0.004188:0.004747:0.009903:0.009192:0.004551:0.004188:0.012564:0.009827:0.009827:0.007590:0.005866:0.004188:0.009903:0.004747:0.004188:0.010357:0.009827:0.003024:0.003024:0.008376:0.009827:0.004551:0.008104:0.004188
27:@0.329242:0.367931:0.338959:0.367931:0.338959:0.358777:0.329242:0.358777:0.004858:0.004858
myxOeDemA COmA:@0.076190:0.406138:0.260239:0.406138:0.260239:0.385973:0.076190:0.385973:0.016631:0.011457:0.012566:0.015522:0.009609:0.012935:0.009609:0.016631:0.013674:0.005174:0.014413:0.015522:0.016631:0.013674
Myxoedema coma is a rare,  but potentially fatal dis-:@0.076190:0.422076:0.480957:0.422076:0.480957:0.406293:0.076190:0.406293:0.013894:0.008104:0.007257:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.006849:0.009782:0.009903:0.014182:0.010326:0.006849:0.003024:0.005866:0.006849:0.010326:0.006849:0.004551:0.010326:0.004551:0.009827:0.004188:0.004188:0.002646:0.010311:0.009192:0.005125:0.006849:0.010311:0.009903:0.005125:0.009827:0.009223:0.005125:0.003024:0.010326:0.003024:0.003024:0.008104:0.006849:0.004747:0.010326:0.005125:0.010326:0.003024:0.006849:0.010357:0.003024:0.005866:0.005020
order which may occur in patients with longstand-:@0.076190:0.436231:0.480942:0.436231:0.480942:0.420448:0.076190:0.420448:0.009903:0.004551:0.010357:0.009827:0.004551:0.009525:0.012564:0.009223:0.003024:0.009782:0.009223:0.009525:0.014182:0.010326:0.008104:0.009525:0.009903:0.009782:0.009782:0.009192:0.004551:0.009525:0.003024:0.009223:0.009525:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.009525:0.012564:0.003024:0.005125:0.009223:0.009525:0.003024:0.009903:0.009223:0.010175:0.005866:0.005125:0.010326:0.009223:0.010357:0.005020
ing  untreated  hypothyroidism.  It  is characterised  by :@0.076190:0.450397:0.485115:0.450397:0.485115:0.434614:0.076190:0.434614:0.003024:0.009223:0.010175:0.004188:0.005020:0.009192:0.009223:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.004188:0.005020:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004188:0.004188:0.005020:0.003417:0.005125:0.004188:0.005020:0.003024:0.005866:0.009223:0.009782:0.009223:0.010326:0.004551:0.010326:0.009782:0.005125:0.009827:0.004551:0.003024:0.005866:0.009827:0.010357:0.004188:0.005020:0.010311:0.008104:0.004188
progressive mental deterioration,  electrolyte abnor-:@0.076190:0.464552:0.480957:0.464552:0.480957:0.448769:0.076190:0.448769:0.010311:0.004551:0.009903:0.010175:0.004551:0.009827:0.005866:0.005866:0.003024:0.008376:0.009827:0.011097:0.014182:0.009827:0.009223:0.005125:0.010326:0.003024:0.011097:0.010357:0.009827:0.005125:0.009827:0.004551:0.003024:0.009903:0.004551:0.010326:0.005125:0.003024:0.009903:0.009223:0.004188:0.004188:0.006894:0.009827:0.003024:0.009827:0.009782:0.005125:0.004551:0.009903:0.003024:0.008104:0.005125:0.009827:0.011097:0.010326:0.010311:0.009223:0.009903:0.004551:0.005020
malities and  organ  dysfunction.   Multiple factors  can :@0.076190:0.478718:0.485132:0.478718:0.485132:0.462936:0.076190:0.462935:0.014182:0.010326:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.006804:0.010326:0.009223:0.010357:0.004188:0.002600:0.009903:0.004551:0.010175:0.010326:0.009223:0.004188:0.002600:0.010357:0.008104:0.005866:0.004747:0.009192:0.009223:0.009782:0.005125:0.003024:0.009903:0.009223:0.004188:0.009724:0.004188:0.002600:0.013894:0.009192:0.003024:0.005125:0.003024:0.010311:0.003024:0.009827:0.006804:0.004747:0.010326:0.009782:0.005125:0.009903:0.004551:0.005866:0.004188:0.002600:0.009782:0.010326:0.009223:0.222354
28:@0.313790:0.473419:0.323506:0.473419:0.323506:0.464266:0.313790:0.464266:0.004858:0.004858
precipitate myxoedema coma, most commonly infec-:@0.076193:0.492873:0.480944:0.492873:0.480944:0.477090:0.076193:0.477090:0.010311:0.004551:0.009827:0.009782:0.003024:0.010311:0.003024:0.005125:0.010326:0.005125:0.009827:0.005246:0.014182:0.008104:0.007257:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.005231:0.009782:0.009903:0.014182:0.010326:0.004188:0.005231:0.014182:0.009903:0.005866:0.005125:0.005231:0.009782:0.009903:0.014182:0.014182:0.009903:0.009223:0.003024:0.008104:0.005231:0.003024:0.009223:0.004747:0.009827:0.009782:0.005020
tions,  particularly  pneumonia  and  urosepsis,  and  cer-:@0.076193:0.507039:0.480929:0.507039:0.480929:0.491257:0.076193:0.491257:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004188:0.003024:0.010311:0.010326:0.004551:0.005125:0.003024:0.009782:0.009192:0.003024:0.010326:0.004551:0.003024:0.008104:0.004188:0.003024:0.010311:0.009223:0.009827:0.009192:0.014182:0.009903:0.009223:0.003024:0.010326:0.004188:0.003024:0.010326:0.009223:0.010357:0.004188:0.003024:0.009192:0.004551:0.009903:0.005866:0.009827:0.010311:0.005866:0.003024:0.005866:0.004188:0.004188:0.003024:0.010326:0.009223:0.010357:0.004188:0.003024:0.009782:0.009827:0.004551:0.005020
tain medications. The patient with myxoedema coma :@0.076193:0.521194:0.485117:0.521194:0.485117:0.505411:0.076193:0.505411:0.005125:0.010326:0.003024:0.009223:0.005957:0.014182:0.009827:0.010357:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.005942:0.006441:0.009223:0.009827:0.005942:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005942:0.012564:0.003024:0.005125:0.009223:0.005942:0.014182:0.008104:0.007257:0.009903:0.009827:0.010357:0.009827:0.014182:0.010326:0.005942:0.009782:0.009903:0.014182:0.010326:0.004188
should be admitted to the intensive care unit, and re-:@0.076193:0.535360:0.480914:0.535360:0.480914:0.519577:0.076193:0.519577:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005715:0.010311:0.009827:0.005715:0.010326:0.010357:0.014182:0.003024:0.005125:0.005125:0.009827:0.010357:0.005715:0.005125:0.009903:0.005715:0.005125:0.009223:0.009827:0.005715:0.003024:0.009223:0.005125:0.009827:0.009223:0.005866:0.003024:0.008376:0.009827:0.005715:0.009782:0.010326:0.004551:0.009827:0.005715:0.009192:0.009223:0.003024:0.005125:0.004188:0.005715:0.010326:0.009223:0.010357:0.005715:0.004551:0.009827:0.005020
ceive treatment with levothyroxine. Mechanical venti-:@0.076193:0.549515:0.480959:0.549515:0.480959:0.533732:0.076193:0.533732:0.009782:0.009827:0.003024:0.008376:0.009827:0.006032:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.006017:0.012564:0.003024:0.005125:0.009223:0.006017:0.003024:0.009827:0.008376:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.004188:0.006017:0.013894:0.009827:0.009782:0.009223:0.010326:0.009223:0.003024:0.009782:0.010326:0.003024:0.006017:0.008376:0.009827:0.009223:0.005125:0.003024:0.005020
lation may be necessary, and hypovolaemia and elec-:@0.076193:0.563681:0.480929:0.563681:0.480929:0.547898:0.076193:0.547898:0.003024:0.010326:0.005125:0.003024:0.009903:0.009223:0.004279:0.014182:0.010326:0.008104:0.004294:0.010311:0.009827:0.004279:0.009223:0.009827:0.009782:0.009827:0.005866:0.005866:0.010326:0.004551:0.008104:0.004188:0.004279:0.010326:0.009223:0.010357:0.004279:0.009223:0.008104:0.010311:0.009903:0.008376:0.009903:0.003024:0.010326:0.009827:0.014182:0.003024:0.010326:0.004294:0.010326:0.009223:0.010357:0.004279:0.009827:0.003024:0.009827:0.009782:0.005020
trolyte abnormalities must be corrected. Because of the :@0.076193:0.577836:0.485147:0.577836:0.485147:0.562053:0.076193:0.562053:0.005125:0.004551:0.009903:0.003024:0.008104:0.005125:0.009827:0.003659:0.010326:0.010311:0.009223:0.009903:0.004551:0.014182:0.010326:0.003024:0.003024:0.005125:0.003024:0.009827:0.005866:0.003674:0.014182:0.009192:0.005866:0.005125:0.003674:0.010311:0.009827:0.003674:0.009782:0.009903:0.004551:0.004551:0.009827:0.009782:0.005125:0.009827:0.010357:0.004188:0.003659:0.008678:0.009827:0.009782:0.010326:0.009192:0.005866:0.009827:0.003674:0.009903:0.004747:0.003659:0.005125:0.009223:0.009827:0.004188
possibility of secondary hypothyroidism and associated :@0.076193:0.592002:0.485132:0.592002:0.485132:0.576219:0.076193:0.576219:0.010311:0.009903:0.005866:0.005866:0.003024:0.010311:0.003024:0.003024:0.003024:0.005125:0.008104:0.004687:0.009903:0.004747:0.004672:0.005866:0.009827:0.009782:0.009903:0.009223:0.010357:0.010326:0.004551:0.008104:0.004672:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.004672:0.010326:0.009223:0.010357:0.004672:0.010326:0.005866:0.005866:0.009903:0.009782:0.003024:0.010326:0.005125:0.009827:0.010357:0.004188
hypopituitarism, hydrocortisone should be administered :@0.076193:0.606157:0.485147:0.606157:0.485147:0.590374:0.076193:0.590374:0.009223:0.008104:0.010311:0.009903:0.010311:0.003024:0.005125:0.009192:0.003024:0.005125:0.010326:0.004551:0.003024:0.005866:0.014182:0.004188:0.004143:0.009223:0.008104:0.010357:0.004551:0.009903:0.009782:0.009903:0.004551:0.005125:0.003024:0.005866:0.009903:0.009223:0.009827:0.004127:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.004143:0.010311:0.009827:0.004143:0.010326:0.010357:0.014182:0.003024:0.009223:0.003024:0.005866:0.005125:0.009827:0.004551:0.009827:0.010357:0.004188
until adrenal insufficiency has been ruled out. :@0.076193:0.620323:0.411850:0.620323:0.411850:0.604540:0.076193:0.604540:0.009192:0.009223:0.005125:0.003024:0.003024:0.004188:0.010326:0.010357:0.004551:0.009827:0.009223:0.010326:0.003024:0.004188:0.003024:0.009223:0.005866:0.009192:0.004747:0.003681:0.003681:0.009782:0.003024:0.009827:0.009223:0.009782:0.008104:0.004188:0.009223:0.010326:0.005866:0.004188:0.010311:0.009827:0.009827:0.009223:0.004188:0.004551:0.009192:0.003024:0.009827:0.010357:0.004188:0.009903:0.009192:0.005125:0.004188:0.004188
COnClusiOn :@0.076190:0.653231:0.203325:0.653231:0.203325:0.633067:0.076190:0.633067:0.014413:0.015522:0.013674:0.014413:0.008131:0.011826:0.009609:0.005174:0.015522:0.013674:0.005174
Hypothyroidism is a common disorder and often over-:@0.076190:0.669170:0.480957:0.669170:0.480957:0.653387:0.076190:0.653387:0.010326:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.005942:0.003024:0.005866:0.005942:0.010326:0.005942:0.009782:0.009903:0.014182:0.014182:0.009903:0.009207:0.005927:0.010357:0.003024:0.005866:0.009903:0.004551:0.010357:0.009827:0.004551:0.005927:0.010326:0.009223:0.010357:0.005942:0.009903:0.004747:0.005125:0.009827:0.009223:0.005927:0.009903:0.008376:0.009827:0.004551:0.005020
looked. It is easily treated with good prognosis. Most pa-:@0.076190:0.683325:0.480957:0.683325:0.480957:0.667542:0.076190:0.667542:0.003024:0.009903:0.009903:0.007590:0.009827:0.010357:0.004188:0.003719:0.003417:0.005125:0.003719:0.003024:0.005866:0.003734:0.009827:0.010326:0.005866:0.003024:0.003024:0.008104:0.003734:0.005125:0.004551:0.009827:0.010326:0.005125:0.009827:0.010357:0.003719:0.012564:0.003024:0.005125:0.009223:0.003719:0.010175:0.009903:0.009903:0.010357:0.003719:0.010311:0.004551:0.009903:0.010175:0.009223:0.009903:0.005866:0.003024:0.005866:0.004188:0.003719:0.013894:0.009903:0.005866:0.005125:0.003719:0.010311:0.010326:0.005020
tients with hypothyroidism can be managed successfully :@0.076190:0.697491:0.485145:0.697491:0.485145:0.681708:0.076190:0.681708:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.002933:0.012564:0.003024:0.005125:0.009223:0.002918:0.009223:0.008104:0.010311:0.009903:0.005125:0.009223:0.008104:0.004551:0.009903:0.003024:0.010357:0.003024:0.005866:0.014182:0.002933:0.009782:0.010326:0.009223:0.002933:0.010311:0.009827:0.002933:0.014182:0.010326:0.009223:0.010326:0.010175:0.009827:0.010357:0.002933:0.005866:0.009192:0.009782:0.009782:0.009827:0.005866:0.005866:0.004747:0.009192:0.003024:0.003024:0.008104:0.004188
in primary care. Most patients require lifelong thyroxine :@0.076190:0.711646:0.485145:0.711646:0.485145:0.695863:0.076190:0.695863:0.003024:0.009223:0.004959:0.010311:0.004551:0.003024:0.014182:0.010326:0.004551:0.008104:0.004959:0.009782:0.010326:0.004551:0.009827:0.004188:0.004959:0.013894:0.009903:0.005866:0.005125:0.004959:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.005866:0.004959:0.004551:0.009827:0.010311:0.009192:0.003024:0.004551:0.009827:0.004959:0.003024:0.003024:0.004747:0.009827:0.003024:0.009903:0.009223:0.010175:0.004959:0.005125:0.009223:0.008104:0.004551:0.009903:0.007257:0.003024:0.009223:0.009827:0.004188
replacement therapy. Referral should be considered if :@0.076190:0.725812:0.485145:0.725812:0.485145:0.710029:0.076190:0.710029:0.004551:0.009827:0.010311:0.003024:0.010326:0.009782:0.009827:0.014182:0.009827:0.009223:0.005125:0.005473:0.005125:0.009223:0.009827:0.004551:0.010326:0.010311:0.008104:0.004188:0.005488:0.009177:0.009827:0.004747:0.009827:0.004551:0.004551:0.010311:0.003024:0.005488:0.005866:0.009223:0.009903:0.009192:0.003024:0.010357:0.005488:0.010311:0.009827:0.005488:0.009782:0.009903:0.009223:0.005866:0.003024:0.010357:0.009827:0.004551:0.009827:0.010357:0.005473:0.003024:0.004747:0.004188
the patient does not respond to adequate treatment, if :@0.076190:0.739967:0.485145:0.739967:0.485145:0.724184:0.076190:0.724184:0.005125:0.009223:0.009827:0.003976:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.003976:0.010357:0.009903:0.009827:0.005866:0.003976:0.009223:0.009903:0.005125:0.003976:0.004551:0.009827:0.005866:0.010311:0.009903:0.009223:0.010357:0.003976:0.005125:0.009903:0.003976:0.010326:0.010357:0.009827:0.010311:0.009192:0.010326:0.005125:0.009827:0.003976:0.005125:0.004551:0.009827:0.010326:0.005125:0.014182:0.009827:0.009223:0.005125:0.004188:0.003961:0.003024:0.004747:0.004188
there is underlying comorbidity or complications, and if :@0.076190:0.754133:0.485130:0.754133:0.485130:0.738350:0.076190:0.738350:0.005125:0.009223:0.009827:0.004551:0.009827:0.004642:0.003024:0.005866:0.004657:0.009192:0.009223:0.010357:0.009827:0.004551:0.003024:0.008104:0.003024:0.009223:0.010175:0.004642:0.009782:0.009903:0.014182:0.009903:0.004551:0.010311:0.003024:0.010357:0.003024:0.005125:0.008104:0.004657:0.009903:0.004551:0.004642:0.009782:0.009903:0.014182:0.010311:0.003024:0.003024:0.009782:0.010326:0.005125:0.003024:0.009903:0.009223:0.005866:0.004188:0.004657:0.010326:0.009223:0.010357:0.004657:0.003024:0.004747:0.004188
the patient is pregnant.:@0.076190:0.768288:0.247731:0.768288:0.247731:0.752505:0.076190:0.752505:0.005125:0.009223:0.009827:0.004188:0.010311:0.010326:0.005125:0.003024:0.009827:0.009223:0.005125:0.004188:0.003024:0.005866:0.004188:0.010311:0.004551:0.009827:0.010175:0.009223:0.010326:0.009223:0.005125:0.004188
referenCes:@0.076190:0.801202:0.182628:0.801202:0.182628:0.781037:0.076190:0.781037:0.010718:0.009609:0.008870:0.009609:0.010718:0.009609:0.013674:0.014413:0.009609:0.009609
1.:@0.076190:0.813145:0.085962:0.813145:0.085962:0.800870:0.076190:0.800870:0.006515:0.003257
Ross  sD. Disorders that cause hypothyroidism. Available  at  www.:@0.101390:0.813145:0.480944:0.813145:0.480944:0.800870:0.101390:0.800870:0.007138:0.007702:0.004563:0.004563:0.003257:0.001834:0.005856:0.008749:0.003257:0.005092:0.008749:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.005092:0.003986:0.007173:0.008032:0.003986:0.005092:0.007608:0.008032:0.007150:0.004563:0.007644:0.005092:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.005092:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.003257:0.001846:0.008032:0.003986:0.003257:0.001834:0.009772:0.009772:0.009772:0.003257
uptodateonline.com. Accessed March 2012.:@0.101390:0.824101:0.355837:0.824101:0.355837:0.811825:0.101390:0.811825:0.007150:0.008020:0.003986:0.007702:0.008055:0.008032:0.003986:0.007644:0.007702:0.007173:0.002352:0.002352:0.007173:0.007644:0.003257:0.007608:0.007702:0.011018:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.010807:0.008032:0.003540:0.007608:0.007173:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
2.:@0.076190:0.835056:0.085962:0.835056:0.085962:0.822781:0.076190:0.822781:0.006515:0.003257
Hallowell JG, staehling NW, Flanders WD, :@0.101390:0.835056:0.341550:0.835056:0.341550:0.822781:0.101390:0.822781:0.008032:0.008032:0.002352:0.002352:0.007702:0.009772:0.007644:0.002352:0.002352:0.004222:0.005668:0.010254:0.003257:0.004210:0.005856:0.003986:0.008032:0.007644:0.007173:0.002352:0.002352:0.007173:0.007914:0.004210:0.008702:0.011289:0.003257:0.004198:0.005703:0.002352:0.008032:0.007173:0.008055:0.007644:0.003540:0.004563:0.004210:0.011289:0.008749:0.003257:0.003257
et al:@0.342502:0.835056:0.368725:0.835056:0.368725:0.822781:0.342502:0.822781:0.007644:0.003986:0.004210:0.008032:0.002352
. serum TsH, T4 and:@0.368725:0.835056:0.480967:0.835056:0.480967:0.822781:0.368725:0.822781:0.003257:0.004210:0.005856:0.007644:0.003540:0.007150:0.011030:0.004198:0.005009:0.005855:0.008032:0.003257:0.004210:0.005009:0.006515:0.004210:0.008032:0.007173:0.008055
thyroid antibodies in the United states population (1988 to 1994)::@0.101390:0.846011:0.480932:0.846011:0.480932:0.833736:0.101390:0.833736:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.004775:0.008032:0.007173:0.003986:0.002352:0.008020:0.007702:0.008055:0.002352:0.007644:0.004563:0.004786:0.002352:0.007173:0.004786:0.003986:0.007173:0.007644:0.004774:0.007702:0.007173:0.002352:0.003986:0.007644:0.008055:0.004774:0.005856:0.003986:0.008032:0.003986:0.007644:0.004563:0.004786:0.008020:0.007702:0.008020:0.007150:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.004774:0.004339:0.006515:0.006515:0.006515:0.006515:0.004786:0.003986:0.007702:0.004774:0.006515:0.006515:0.006515:0.006515:0.004339:-0.259948
National Health and Nutrition Examination survey (NHANEs III). :@0.101390:0.856967:0.451816:0.856967:0.451816:0.844691:0.101390:0.844691:0.008702:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.002634:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.002634:0.008032:0.007173:0.008055:0.002634:0.008702:0.007150:0.003986:0.003540:0.002352:0.003986:0.002352:0.007702:0.007173:0.002622:0.006303:0.005644:0.008032:0.011030:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.002634:0.005856:0.007150:0.003540:0.006515:0.007644:0.006303:0.002634:0.004339:0.008702:0.008032:0.008702:0.008702:0.006303:0.005856:0.002634:0.002658:0.002658:0.002658:0.004339:0.003257:-0.245179
J Clin :@0.451193:0.856967:0.484189:0.856967:0.484189:0.844691:0.451193:0.844691:0.005668:0.002634:0.009560:0.002352:0.002352:0.007173:0.003257
Endocrinol Metab.:@0.101390:0.867922:0.206354:0.867922:0.206354:0.855647:0.101390:0.855647:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.003257:0.010807:0.007644:0.003986:0.008032:0.008020:0.003257
 2002; 87(2):489-499.:@0.206342:0.867922:0.319901:0.867922:0.319901:0.855647:0.206342:0.855647:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
3.:@0.076190:0.878877:0.085962:0.878877:0.085962:0.866602:0.076190:0.866602:0.006515:0.003257
Aoki Y, Belin RM, Clickner R, :@0.101390:0.878877:0.259188:0.878877:0.259188:0.866602:0.101390:0.866602:0.008702:0.007702:0.005903:0.002352:0.003128:0.006961:0.003257:0.003140:0.006750:0.007644:0.002352:0.002352:0.007173:0.003140:0.007138:0.010807:0.003257:0.003128:0.009560:0.002352:0.002352:0.007608:0.005903:0.007173:0.007644:0.003540:0.003128:0.007138:0.003257:-0.081243
et al:@0.259070:0.878877:0.284212:0.878877:0.284212:0.866602:0.259070:0.866602:0.007644:0.003986:0.003128:0.008032:0.002352
. serum TsH and total T4 in the Unit-:@0.284212:0.878877:0.480956:0.878877:0.480956:0.866602:0.284212:0.866602:0.003257:0.003140:0.005856:0.007644:0.003540:0.007150:0.011030:0.003128:0.005009:0.005856:0.008032:0.003140:0.008032:0.007173:0.008055:0.003140:0.003986:0.007702:0.003986:0.008032:0.002352:0.003128:0.005009:0.006515:0.003140:0.002352:0.007173:0.003140:0.003986:0.007173:0.007644:0.003128:0.007702:0.007173:0.002352:0.003986:0.003904
ed states population and their association with participant charac-:@0.101390:0.889833:0.480956:0.889833:0.480956:0.877557:0.101390:0.877557:0.007644:0.008055:0.002881:0.005856:0.003986:0.008032:0.003986:0.007644:0.004563:0.002881:0.008020:0.007702:0.008020:0.007150:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.002881:0.008032:0.007173:0.008055:0.002881:0.003986:0.007173:0.007644:0.002352:0.003540:0.002869:0.008032:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.002869:0.009772:0.002352:0.003986:0.007173:0.002869:0.008020:0.008032:0.003540:0.003986:0.002352:0.007608:0.002352:0.008020:0.008032:0.007173:0.003986:0.002881:0.007608:0.007173:0.008032:0.003540:0.008032:0.007608:-0.316710
teristics: National Health and Nutrition Examination survey (NHANEs:@0.101390:0.900788:0.480956:0.900788:0.480956:0.888513:0.101390:0.888513:0.003986:0.007644:0.003540:0.002352:0.004563:0.003986:0.002352:0.007608:0.004563:0.003257:0.003222:0.008702:0.008032:0.003986:0.002352:0.007702:0.007173:0.008032:0.002352:0.003222:0.008032:0.007644:0.008032:0.002352:0.003986:0.007173:0.003222:0.008032:0.007173:0.008055:0.003222:0.008702:0.007150:0.003986:0.003540:0.002352:0.003986:0.002352:0.007702:0.007173:0.003210:0.006303:0.005644:0.008032:0.011030:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.003222:0.005856:0.007150:0.003540:0.006515:0.007644:0.006303:0.003222:0.004339:0.008702:0.008032:0.008702:0.008702:0.006303:-0.329104
1999-2002). :@0.101390:0.911744:0.168265:0.911744:0.168265:0.899468:0.101390:0.899468:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.004339:0.003257:0.003257
Thyroid. :@0.168277:0.911744:0.214926:0.911744:0.214926:0.899468:0.168277:0.899468:0.005009:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003257:0.003257
2007;17(12): 1211-23.:@0.214914:0.911744:0.331731:0.911744:0.331731:0.899468:0.214914:0.899468:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.006515:0.004339:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
4.:@0.076179:0.922699:0.085951:0.922699:0.085951:0.910423:0.076179:0.910423:0.006515:0.003257
Vanderpump Mp, Tunbridge WM, French JM, :@0.101379:0.922699:0.356719:0.922699:0.356719:0.910423:0.101379:0.910423:0.008255:0.008032:0.007173:0.008055:0.007644:0.003540:0.008020:0.007150:0.011030:0.008020:0.002681:0.010807:0.006961:0.003257:0.002669:0.005009:0.007150:0.007173:0.008020:0.003540:0.002352:0.008055:0.007914:0.007644:0.002669:0.011289:0.010807:0.003257:0.002669:0.005703:0.003540:0.007644:0.007173:0.007608:0.007173:0.002669:0.005668:0.010807:0.003257:-0.236159
et al.:@0.356143:0.922699:0.384083:0.922699:0.384083:0.910423:0.356143:0.910423:0.007644:0.003986:0.002669:0.008032:0.002352:0.003257
 The incidence of :@0.384083:0.922699:0.484201:0.922699:0.484201:0.910423:0.384083:0.910423:0.002681:0.005009:0.007173:0.007644:0.002669:0.002352:0.007173:0.007608:0.002352:0.008055:0.007644:0.007173:0.007608:0.007644:0.002681:0.007702:0.003692:0.003257
thyroid disorders in the community: A twenty-year follow-up of the:@0.101379:0.933654:0.480967:0.933654:0.480967:0.921379:0.101379:0.921379:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003857:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003857:0.002352:0.007173:0.003857:0.003986:0.007173:0.007644:0.003857:0.007608:0.007702:0.011030:0.011030:0.007150:0.007173:0.002352:0.003986:0.006303:0.003257:0.003857:0.008702:0.003857:0.003986:0.009772:0.007644:0.007173:0.003986:0.006303:0.003904:0.006303:0.007644:0.008032:0.003540:0.003857:0.003692:0.007702:0.002352:0.002352:0.007702:0.009772:0.003904:0.007150:0.008020:0.003857:0.007702:0.003692:0.003857:0.003986:0.007173:0.007644
Whickham survey. :@0.101379:0.944610:0.207424:0.944610:0.207424:0.932334:0.101379:0.932334:0.011289:0.007173:0.002352:0.007608:0.005903:0.007173:0.008032:0.011030:0.003257:0.004563:0.007150:0.003540:0.006515:0.007644:0.006303:0.003257:0.003257
Clin Endocrinol.:@0.207424:0.944610:0.295336:0.944610:0.295336:0.932334:0.207424:0.932334:0.009560:0.002352:0.002352:0.007173:0.003257:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.003257
1995;43:55-68.:@0.295336:0.944610:0.374158:0.944610:0.374158:0.932334:0.295336:0.932334:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.003257
5. :@0.519032:0.238609:0.532061:0.238609:0.532061:0.226334:0.519032:0.226334:0.006515:0.003257:0.003257
sawin CT, Castelli Wp, Hershman JM, :@0.544232:0.238609:0.771985:0.238609:0.771985:0.226334:0.544232:0.226334:0.005856:0.008032:0.009772:0.002352:0.007173:0.006844:0.009560:0.005009:0.003257:0.006844:0.009560:0.008032:0.004563:0.003986:0.007644:0.002352:0.002352:0.002352:0.006844:0.011289:0.006961:0.003257:0.006844:0.008032:0.007644:0.003540:0.004563:0.007173:0.011030:0.008032:0.007173:0.006844:0.005668:0.010807:0.003257:0.003257
et al:@0.775572:0.238609:0.804429:0.238609:0.804429:0.226334:0.775572:0.226334:0.007644:0.003986:0.006844:0.008032:0.002352
. The aging thyroid.:@0.804429:0.238609:0.923797:0.238609:0.923797:0.226334:0.804429:0.226334:0.003257:0.006844:0.005009:0.007173:0.007644:0.006844:0.008032:0.007914:0.002352:0.007173:0.007914:0.006844:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003257
Thyroid  deficiency  in  the  Framingham  Study. :@0.544232:0.249511:0.819340:0.249511:0.819340:0.237235:0.544232:0.237235:0.005009:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003257:0.004080:0.008055:0.007644:0.002863:0.002863:0.007608:0.002352:0.007644:0.007173:0.007608:0.006303:0.003257:0.004080:0.002352:0.007173:0.003257:0.004080:0.003986:0.007173:0.007644:0.003257:0.004080:0.005703:0.003540:0.008032:0.011030:0.002352:0.007173:0.007914:0.007173:0.008032:0.011030:0.003257:0.004080:0.005856:0.003986:0.007150:0.008055:0.006303:0.003257:0.003257
Arch  Intern  Med :@0.823432:0.249511:0.927066:0.249511:0.927066:0.237235:0.823432:0.237235:0.008702:0.003540:0.007608:0.007173:0.003257:0.004080:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.003257:0.004080:0.010807:0.007644:0.008055:0.003257
1985;145(8):1386-1388. :@0.544232:0.260412:0.674078:0.260412:0.674078:0.248137:0.544232:0.248137:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257
6.:@0.519032:0.271314:0.528804:0.271314:0.528804:0.259038:0.519032:0.259038:0.006515:0.003257
Laurberg p, Andersen s, Bülow pedersen I, Carlé A. Hypothyroidism:@0.544232:0.271314:0.923797:0.271314:0.923797:0.259038:0.544232:0.259038:0.005433:0.008032:0.007150:0.003540:0.008020:0.007644:0.003540:0.007914:0.003481:0.006961:0.003257:0.003492:0.008702:0.007173:0.008055:0.007644:0.003540:0.004563:0.007644:0.007173:0.003492:0.005856:0.003257:0.003481:0.006750:0.007150:0.002352:0.007702:0.009772:0.003492:0.006961:0.007644:0.008055:0.007644:0.003540:0.004563:0.007644:0.007173:0.003492:0.002658:0.003257:0.003492:0.009560:0.008032:0.003540:0.002352:0.007644:0.003492:0.008702:0.003257:0.003492:0.008032:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030
in the elderly: pathophysiology, diagnosis and treatment. :@0.544232:0.282215:0.868646:0.282215:0.868646:0.269940:0.544232:0.269940:0.002352:0.007173:0.002987:0.003986:0.007173:0.007644:0.002987:0.007644:0.002352:0.008055:0.007644:0.003540:0.002352:0.006303:0.003257:0.002999:0.006961:0.008032:0.003986:0.007173:0.007702:0.008020:0.007173:0.006303:0.004563:0.002352:0.007702:0.002352:0.007702:0.007914:0.006303:0.003257:0.002987:0.008055:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.002352:0.004563:0.002999:0.008032:0.007173:0.008055:0.002987:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.090642
Drugs Ag-:@0.868376:0.282215:0.923797:0.282215:0.923797:0.269940:0.868376:0.269940:0.008749:0.003540:0.007150:0.007914:0.004563:0.002987:0.008702:0.007914:0.003904
ing.:@0.544232:0.293117:0.564928:0.293117:0.564928:0.280841:0.544232:0.280841:0.002352:0.007173:0.007914:0.003257
 2005; 22(1):23- 38.:@0.564928:0.293117:0.668716:0.293117:0.668716:0.280841:0.564928:0.280841:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.003257:0.006515:0.006515:0.003257
7. :@0.519032:0.304018:0.531826:0.304018:0.531826:0.291743:0.519032:0.291743:0.006397:0.003140:0.398911
American Association of Clinical Endocrinologists Thyroid Task Force. :@0.544232:0.304018:0.927078:0.304018:0.927078:0.291743:0.544232:0.291743:0.008584:0.010913:0.007526:0.003422:0.002234:0.007491:0.007914:0.007056:0.003234:0.008584:0.004445:0.004445:0.007585:0.007491:0.002234:0.007914:0.003869:0.002234:0.007585:0.007056:0.003234:0.007585:0.003575:0.003234:0.009443:0.002234:0.002234:0.007056:0.002234:0.007491:0.007914:0.002234:0.003234:0.006185:0.007056:0.007937:0.007585:0.007491:0.003422:0.002234:0.007056:0.007585:0.002234:0.007585:0.007796:0.002234:0.004445:0.003869:0.004445:0.003234:0.004892:0.007056:0.006185:0.003422:0.007585:0.002234:0.007937:0.003234:0.004892:0.007914:0.004445:0.005786:0.003234:0.005586:0.007585:0.003422:0.007491:0.007526:0.003257:0.003257
American  Association  of  Clinical  Endocrinologists  medical  guide-:@0.544232:0.314920:0.923762:0.314920:0.923762:0.302644:0.544232:0.302644:0.008584:0.010913:0.007526:0.003422:0.002234:0.007491:0.007914:0.007056:0.003257:0.002928:0.008584:0.004445:0.004445:0.007585:0.007491:0.002234:0.007914:0.003869:0.002234:0.007585:0.007056:0.003257:0.002928:0.007585:0.003575:0.003257:0.002928:0.009443:0.002234:0.002234:0.007056:0.002234:0.007491:0.007914:0.002234:0.003257:0.002928:0.006185:0.007056:0.007937:0.007585:0.007491:0.003422:0.002234:0.007056:0.007585:0.002234:0.007585:0.007796:0.002234:0.004445:0.003869:0.004445:0.003257:0.002928:0.010913:0.007526:0.007937:0.002234:0.007491:0.007914:0.002234:0.003257:0.002928:0.007796:0.007032:0.002234:0.007937:0.007526:0.003904
lines for clinical practice for the evaluation and treatment of hyper-:@0.544232:0.325821:0.923844:0.325821:0.923844:0.313546:0.544232:0.313546:0.002234:0.002234:0.007056:0.007526:0.004445:0.003598:0.003575:0.007585:0.003422:0.003598:0.007491:0.002234:0.002234:0.007056:0.002234:0.007491:0.007914:0.002234:0.003598:0.007902:0.003422:0.007914:0.007491:0.003869:0.002234:0.007491:0.007526:0.003598:0.003575:0.007585:0.003422:0.003598:0.003869:0.007056:0.007526:0.003598:0.007526:0.006397:0.007914:0.002234:0.007032:0.007914:0.003869:0.002234:0.007585:0.007056:0.003598:0.007914:0.007056:0.007937:0.003598:0.003869:0.003422:0.007526:0.007914:0.003869:0.010913:0.007526:0.007056:0.003869:0.003598:0.007585:0.003575:0.003598:0.007056:0.006185:0.007902:0.007526:0.003422:0.003904
thyroidism and hypothyroidism. :@0.544232:0.336722:0.720303:0.336722:0.720303:0.324447:0.544232:0.324447:0.003869:0.007056:0.006185:0.003422:0.007585:0.002234:0.007937:0.002234:0.004445:0.010913:0.003140:0.007914:0.007056:0.007937:0.003140:0.007056:0.006185:0.007902:0.007585:0.003869:0.007056:0.006185:0.003422:0.007585:0.002234:0.007937:0.002234:0.004445:0.010913:0.003140:0.003257
Endocr Pract.:@0.720186:0.336722:0.795798:0.336722:0.795798:0.324447:0.720186:0.324447:0.006185:0.007056:0.007937:0.007585:0.007491:0.003422:0.003140:0.006844:0.003422:0.007914:0.007491:0.003869:0.003257
 2002;8(6):457-469.:@0.795680:0.336722:0.897351:0.336722:0.897351:0.324447:0.795680:0.324447:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.006397:0.006397:0.003257
8.:@0.519032:0.347624:0.528804:0.347624:0.528804:0.335349:0.519032:0.335349:0.006515:0.003257
Dayan CM, Daniels GH. Chronic autoimmune thyroiditis. :@0.544232:0.347624:0.874549:0.347624:0.874549:0.335349:0.544232:0.335349:0.008749:0.008032:0.006303:0.008032:0.007173:0.004798:0.009560:0.010807:0.003257:0.004798:0.008749:0.008032:0.007173:0.002352:0.007644:0.002352:0.004563:0.004798:0.010254:0.008032:0.003257:0.004798:0.009560:0.007173:0.003540:0.007702:0.007173:0.002352:0.007608:0.004786:0.008032:0.007150:0.003986:0.007702:0.002352:0.011030:0.011030:0.007150:0.007173:0.007644:0.004786:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.003986:0.002352:0.004563:0.003257:-0.000915
N Engl J:@0.876090:0.347624:0.923797:0.347624:0.923797:0.335349:0.876090:0.335349:0.008702:0.004798:0.006303:0.007173:0.007914:0.002352:0.004798:0.005668
Med.:@0.544232:0.358525:0.573995:0.358525:0.573995:0.346250:0.544232:0.346250:0.010807:0.007644:0.008055:0.003257
 1996; 335(2):99-107. :@0.573995:0.358525:0.690811:0.358525:0.690811:0.346250:0.573995:0.346250:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257:0.003257
9.:@0.519032:0.369427:0.528804:0.369427:0.528804:0.357152:0.519032:0.357152:0.006515:0.003257
Roberts  CGp,  Ladenson  pW.  Hypothyroidism.  seminar. :@0.544232:0.369427:0.876043:0.369427:0.876043:0.357152:0.544232:0.357152:0.007138:0.007702:0.008020:0.007644:0.003540:0.003986:0.004563:0.003257:0.004621:0.009560:0.010254:0.006961:0.003257:0.003257:0.004621:0.005433:0.008032:0.008055:0.007644:0.007173:0.004563:0.007702:0.007173:0.003257:0.004621:0.006961:0.011289:0.003257:0.003257:0.004621:0.008032:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003257:0.004621:0.005856:0.007644:0.011030:0.002352:0.007173:0.008032:0.003540:0.003257:0.003257
Lancet. :@0.880664:0.369427:0.927055:0.369427:0.927055:0.357152:0.880664:0.357152:0.005433:0.008032:0.007173:0.007608:0.007644:0.003986:0.003257:0.003257
2004; 363(9411): 793-803.:@0.544232:0.380328:0.683850:0.380328:0.683850:0.368053:0.544232:0.368053:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.006515:0.006515:0.006515:0.004339:0.003257:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
10. Zimmerman MB, Jooste PL, Pandav CS. Iodine-deficiency disorders. :@0.519032:0.391230:0.927055:0.391230:0.927055:0.378954:0.519032:0.378954:0.006515:0.006515:0.003257:0.008914:0.005644:0.002352:0.011030:0.011030:0.007644:0.003540:0.011030:0.008032:0.007173:0.003151:0.010807:0.006750:0.003257:0.003151:0.005668:0.007702:0.007702:0.004563:0.003986:0.007644:0.003140:0.006961:0.005433:0.003257:0.003151:0.006961:0.008032:0.007173:0.008055:0.008032:0.006515:0.003151:0.009560:0.005856:0.003257:0.003151:0.002658:0.007702:0.008055:0.002352:0.007173:0.007644:0.003904:0.008055:0.007644:0.002863:0.002863:0.007608:0.002352:0.007644:0.007173:0.007608:0.006303:0.003151:0.008055:0.002352:0.004563:0.007702:0.003540:0.008055:0.007644:0.003540:0.004563:0.003257:0.003257
Lancet.:@0.544232:0.402131:0.587365:0.402131:0.587365:0.389856:0.544232:0.389856:0.005433:0.008032:0.007173:0.007608:0.007644:0.003986:0.003257
 2008;372:1251-1262.:@0.587353:0.402131:0.702006:0.402131:0.702006:0.389856:0.587353:0.389856:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257
11. Lania A, persani L, Beck, peccoz p. Central hypothyroidism. :@0.519032:0.413033:0.876466:0.413033:0.876466:0.400757:0.519032:0.400757:0.006515:0.006515:0.003257:0.008914:0.005433:0.008032:0.007173:0.002352:0.008032:0.002669:0.008702:0.003257:0.002669:0.006961:0.007644:0.003540:0.004563:0.008032:0.007173:0.002352:0.002669:0.005433:0.003257:0.002669:0.006750:0.007644:0.007608:0.005903:0.003257:0.002669:0.006961:0.007644:0.007608:0.007608:0.007702:0.004998:0.002658:0.006961:0.003257:0.002669:0.009560:0.007644:0.007173:0.003986:0.003540:0.008032:0.002352:0.002669:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003257
Pituitary.:@0.875878:0.413033:0.923797:0.413033:0.923797:0.400757:0.875878:0.400757:0.006961:0.002352:0.003986:0.007150:0.002352:0.003986:0.008032:0.003540:0.006303:0.003257
2008;11:181-186.:@0.544232:0.423934:0.636084:0.423934:0.636084:0.411659:0.544232:0.411659:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
12. Fauci As, Braunwald E, Isselbacher KJ, Wilson JD, Martin JB, :@0.519032:0.434836:0.892529:0.434836:0.892529:0.422560:0.519032:0.422560:0.006515:0.006515:0.003257:0.008914:0.005703:0.008032:0.007150:0.007608:0.002352:0.004621:0.008702:0.005856:0.003257:0.004621:0.006750:0.003540:0.008032:0.007150:0.007173:0.009772:0.008032:0.002352:0.008055:0.004633:0.006303:0.003257:0.004621:0.002658:0.004563:0.004563:0.007644:0.002352:0.008020:0.008032:0.007608:0.007185:0.007644:0.003540:0.004621:0.006950:0.005668:0.003257:0.004621:0.011289:0.002352:0.002352:0.004563:0.007702:0.007173:0.004633:0.005668:0.008749:0.003257:0.004621:0.010807:0.008032:0.003540:0.003986:0.002352:0.007173:0.004621:0.005668:0.006750:0.003257:-0.133101
et al:@0.893905:0.434836:0.920540:0.434836:0.920540:0.422560:0.893905:0.422560:0.007644:0.003986:0.004621:0.008032:0.002352
, :@0.920540:0.434836:0.927055:0.434836:0.927055:0.422560:0.920540:0.422560:0.003257:0.003257
editors. :@0.544232:0.445737:0.588588:0.445737:0.588588:0.433462:0.544232:0.433462:0.007644:0.008055:0.002352:0.003986:0.007702:0.003540:0.004563:0.003257:0.003257
Harrison’s principles of internal medicine:@0.588470:0.445737:0.815812:0.445737:0.815812:0.433462:0.588470:0.433462:0.008032:0.008032:0.003540:0.003540:0.002352:0.004563:0.007702:0.007173:0.004127:0.004563:0.003151:0.008020:0.003540:0.002352:0.007173:0.007608:0.002352:0.008020:0.002352:0.007644:0.004563:0.003151:0.007702:0.003692:0.003151:0.002352:0.007173:0.003986:0.007644:0.003540:0.007173:0.008032:0.002352:0.003140:0.011030:0.007644:0.008055:0.002352:0.007608:0.002352:0.007173:0.007644
.16th Ed. New York: :@0.815812:0.445737:0.927055:0.445737:0.927055:0.433462:0.815812:0.433462:0.003257:0.006515:0.006515:0.003986:0.007173:0.003151:0.006303:0.008055:0.003257:0.003151:0.008702:0.007644:0.009772:0.003140:0.006961:0.007702:0.003540:0.005903:0.003257:0.003257
McGraw Hill; 2005.:@0.544232:0.456639:0.648419:0.456639:0.648419:0.444363:0.544232:0.444363:0.010807:0.007608:0.010254:0.003540:0.008032:0.009772:0.003257:0.008032:0.002352:0.002352:0.002352:0.003257:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
13.  surks  MI.  Clinical manifestations of  hyperthyroidism.  Available at :@0.519032:0.467540:0.927043:0.467540:0.927043:0.455265:0.519032:0.455265:0.006515:0.006515:0.003257:0.003257:0.005656:0.005856:0.007150:0.003540:0.005903:0.004563:0.003257:0.002646:0.010807:0.002658:0.003257:0.003257:0.002646:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.005915:0.011030:0.008032:0.007173:0.002352:0.003692:0.007644:0.004563:0.003986:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:0.005915:0.007702:0.003692:0.003257:0.002646:0.007173:0.006303:0.008020:0.007644:0.003540:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003257:0.002646:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.005915:0.008032:0.003986:0.003257
www.uptodateonline.com. Accessed March 2012:@0.544232:0.478442:0.827995:0.478442:0.827995:0.466166:0.544232:0.466166:0.009772:0.009772:0.009772:0.003257:0.007150:0.008020:0.003986:0.007702:0.008055:0.008032:0.003986:0.007644:0.007702:0.007173:0.002352:0.002352:0.007173:0.007644:0.003257:0.007608:0.007702:0.011018:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.010807:0.008032:0.003540:0.007608:0.007173:0.003257:0.006515:0.006515:0.006515:0.006515
14. Vaidya  B, pearce sHs. Management of hypothyroidism in adults.:@0.519032:0.489343:0.923785:0.489343:0.923785:0.477068:0.519032:0.477068:0.006515:0.006515:0.003257:0.008914:0.008255:0.008032:0.002352:0.008055:0.006303:0.008032:0.003257:0.001764:0.006750:0.003257:0.005009:0.006961:0.007644:0.008032:0.003540:0.007608:0.007644:0.005009:0.005856:0.008032:0.005856:0.003257:0.005009:0.010807:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.005009:0.007702:0.003692:0.005009:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.005009:0.002352:0.007173:0.005009:0.008032:0.008055:0.007150:0.002352:0.003986:0.004563:-0.235736
Clinical review. :@0.544232:0.500245:0.633250:0.500245:0.633250:0.487969:0.544232:0.487969:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003257:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003257:0.003257
BMJ.:@0.633250:0.500245:0.659731:0.500245:0.659731:0.487969:0.633250:0.487969:0.006750:0.010807:0.005668:0.003257
 2008; 337:284-289.:@0.659731:0.500245:0.764612:0.500245:0.764612:0.487969:0.659731:0.487969:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
15. Ross sD. Diagnosis of and screening for hypothyroidism. Available at :@0.519032:0.511146:0.927066:0.511146:0.927066:0.498871:0.519032:0.498871:0.006515:0.006515:0.003257:0.008914:0.007138:0.007702:0.004563:0.004563:0.002622:0.005856:0.008749:0.003257:0.002622:0.008749:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.002352:0.004563:0.002634:0.007702:0.003692:0.002622:0.008032:0.007173:0.008055:0.002622:0.004563:0.007608:0.003540:0.007644:0.007644:0.007173:0.002352:0.007173:0.007914:0.002622:0.003692:0.007702:0.003540:0.002622:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.002622:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.002634:0.008032:0.003986:0.003257
www.uptodateonline.com. Accessed March 2012:@0.544232:0.522047:0.827995:0.522047:0.827995:0.509772:0.544232:0.509772:0.009772:0.009772:0.009772:0.003257:0.007150:0.008020:0.003986:0.007702:0.008055:0.008032:0.003986:0.007644:0.007702:0.007173:0.002352:0.002352:0.007173:0.007644:0.003257:0.007608:0.007702:0.011018:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.010807:0.008032:0.003540:0.007608:0.007173:0.003257:0.006515:0.006515:0.006515:0.006515
16. De  los  Santos  ET,  Starich  GH,  Mazzaferri  EL.  Sensitivity,  specificity, :@0.519032:0.532949:0.927043:0.532949:0.927043:0.520674:0.519032:0.520674:0.006515:0.006515:0.003257:0.008914:0.008749:0.007644:0.003257:0.002093:0.002352:0.007702:0.004563:0.003257:0.002105:0.005856:0.008032:0.007173:0.003986:0.007702:0.004563:0.003257:0.002093:0.006303:0.005009:0.003257:0.003257:0.002093:0.005856:0.003986:0.008032:0.003540:0.002352:0.007608:0.007173:0.003257:0.002093:0.010254:0.008032:0.003257:0.003257:0.002105:0.010807:0.008032:0.004998:0.004998:0.008032:0.003692:0.007644:0.003540:0.003540:0.002352:0.003257:0.002093:0.006303:0.005433:0.003257:0.003257:0.002093:0.005856:0.007644:0.007173:0.004563:0.002352:0.003986:0.002352:0.006515:0.002352:0.003986:0.006303:0.003257:0.003257:0.002105:0.004563:0.008020:0.007644:0.007608:0.002352:0.002863:0.002863:0.007608:0.002352:0.003986:0.006303:0.003257:0.003257
and cost-effectiveness of the sensitive thyrotropin assay in the diag-:@0.544232:0.543850:0.923797:0.543850:0.923797:0.531575:0.544232:0.531575:0.008032:0.007173:0.008055:0.002810:0.007608:0.007702:0.004563:0.003986:0.003904:0.007644:0.003692:0.003692:0.007644:0.007608:0.003986:0.002352:0.006515:0.007644:0.007173:0.007644:0.004563:0.004563:0.002810:0.007702:0.003692:0.002810:0.003986:0.007173:0.007644:0.002810:0.004563:0.007644:0.007173:0.004563:0.002352:0.003986:0.002352:0.006515:0.007644:0.002810:0.003986:0.007173:0.006303:0.003540:0.007702:0.003986:0.003540:0.007702:0.008020:0.002352:0.007173:0.002799:0.008032:0.004563:0.004563:0.008032:0.006303:0.002822:0.002352:0.007173:0.002810:0.003986:0.007173:0.007644:0.002799:0.008055:0.002352:0.008032:0.007914:0.003904
nosis of thyroid  disease in ambulatory patients. :@0.544232:0.554752:0.822703:0.554752:0.822703:0.542476:0.544232:0.542476:0.007173:0.007702:0.004563:0.002352:0.004563:0.005139:0.007702:0.003692:0.005139:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003257:0.001870:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.005139:0.002352:0.007173:0.005139:0.008032:0.011030:0.008020:0.007150:0.002352:0.008032:0.003986:0.007702:0.003540:0.006303:0.005139:0.008020:0.008032:0.003986:0.002352:0.007644:0.007173:0.003986:0.004563:0.003257:0.003257
Arch  Intern  Med.:@0.824584:0.554752:0.923797:0.554752:0.923797:0.542476:0.824584:0.542476:0.008702:0.003540:0.007608:0.007173:0.003257:0.001870:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.003257:0.001870:0.010807:0.007644:0.008055:0.003257
1989;149:526-532. :@0.544232:0.565653:0.645856:0.565653:0.645856:0.553378:0.544232:0.553378:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257:0.003257
17. Ross sD. Treatment of hypothyroidism. Available at www.uptodate-:@0.519032:0.576555:0.923809:0.576555:0.923809:0.564279:0.519032:0.564279:0.006515:0.006515:0.003257:0.008914:0.007138:0.007702:0.004563:0.004563:0.003104:0.005856:0.008749:0.003257:0.003104:0.005009:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003093:0.007702:0.003692:0.003104:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003104:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.003116:0.008032:0.003986:0.003104:0.009772:0.009772:0.009772:0.003257:0.007150:0.008020:0.003986:0.007702:0.008055:0.008032:0.003986:0.007644:-0.349318
online.com. Accessed March 2012:@0.544232:0.587456:0.740847:0.587456:0.740847:0.575181:0.544232:0.575181:0.007702:0.007173:0.002352:0.002352:0.007173:0.007644:0.003257:0.007608:0.007702:0.011018:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.010807:0.008032:0.003540:0.007608:0.007173:0.003257:0.006515:0.006515:0.006515:0.006515
18. Roos A, Linn-Rasker sp, van Domburg RT. The starting dose of levo-:@0.519032:0.598358:0.923821:0.598358:0.923821:0.586082:0.519032:0.586082:0.006515:0.006515:0.003257:0.008914:0.007138:0.007702:0.007702:0.004563:0.003775:0.008702:0.003257:0.003775:0.005433:0.002352:0.007173:0.007173:0.003904:0.007138:0.008032:0.004563:0.005903:0.007644:0.003540:0.003775:0.005856:0.006961:0.003257:0.003775:0.006515:0.008032:0.007173:0.003775:0.008749:0.007702:0.011030:0.008020:0.007150:0.003540:0.007914:0.003775:0.007138:0.005009:0.003257:0.003775:0.005009:0.007173:0.007644:0.003775:0.004563:0.003986:0.008032:0.003540:0.003986:0.002352:0.007173:0.007914:0.003775:0.008055:0.007702:0.004563:0.007644:0.003775:0.007702:0.003692:0.003775:0.002352:0.007644:0.006515:0.007702:0.003904
thyroxine  in primary hypothyroidism treatment. :@0.544232:0.609259:0.820868:0.609259:0.820868:0.596984:0.544232:0.596984:0.003986:0.007173:0.006303:0.003540:0.007702:0.005644:0.002352:0.007173:0.007644:0.003257:0.002481:0.002352:0.007173:0.005750:0.008020:0.003540:0.002352:0.011030:0.008032:0.003540:0.006303:0.005750:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.005750:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.003257
Arch  Intern  Med.:@0.823350:0.609259:0.923785:0.609259:0.923785:0.596984:0.823350:0.596984:0.008702:0.003540:0.007608:0.007173:0.003257:0.002481:0.002658:0.007173:0.003986:0.007644:0.003540:0.007173:0.003257:0.002481:0.010807:0.007644:0.008055:0.003257
 :@0.923785:0.609259:0.927043:0.609259:0.927043:0.596984:0.923785:0.596984:0.003257
2005;165:1714-1720.:@0.544232:0.620161:0.655627:0.620161:0.655627:0.607885:0.544232:0.607885:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257
19. Dong BJ, Hauck WW, Gambertoglio JG, Gee L, White JR, :@0.519032:0.631062:0.870704:0.631062:0.870704:0.618787:0.519032:0.618787:0.006515:0.006515:0.003257:0.008914:0.008749:0.007702:0.007173:0.007914:0.003445:0.006750:0.005668:0.003257:0.003445:0.008032:0.008032:0.007150:0.007608:0.005903:0.003445:0.011289:0.011289:0.003257:0.003445:0.010254:0.008032:0.011030:0.008020:0.007644:0.003540:0.003986:0.007702:0.007902:0.002352:0.002352:0.007702:0.003445:0.005668:0.010254:0.003257:0.003445:0.010254:0.007644:0.007644:0.003445:0.005433:0.003257:0.003445:0.011289:0.007173:0.002352:0.003986:0.007644:0.003445:0.005668:0.007138:0.003257:-0.368239
et al:@0.870892:0.631062:0.896351:0.631062:0.896351:0.618787:0.870892:0.618787:0.007644:0.003986:0.003445:0.008032:0.002352
. Bio-:@0.896351:0.631062:0.923762:0.631062:0.923762:0.618787:0.896351:0.618787:0.003257:0.003445:0.006750:0.002352:0.007702:0.003904
equivalence of generic and brand-name levothyroxine products in :@0.544232:0.641964:0.927055:0.641964:0.927055:0.629688:0.544232:0.629688:0.007644:0.008020:0.007150:0.002352:0.006515:0.008032:0.002352:0.007644:0.007173:0.007608:0.007644:0.002928:0.007702:0.003692:0.002916:0.007914:0.007644:0.007173:0.007644:0.003540:0.002352:0.007608:0.002916:0.008032:0.007173:0.008055:0.002916:0.008020:0.003540:0.008032:0.007173:0.008055:0.003904:0.007173:0.008032:0.011030:0.007644:0.002916:0.002352:0.007644:0.006515:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.005644:0.002352:0.007173:0.007644:0.002916:0.008020:0.003540:0.007702:0.008055:0.007150:0.007608:0.003986:0.004563:0.002916:0.002352:0.007173:0.003257
the treatment of hypothyroidism. :@0.544232:0.652865:0.733991:0.652865:0.733991:0.640590:0.544232:0.640590:0.003986:0.007173:0.007644:0.003257:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.007702:0.003692:0.003257:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003257
JAMA.:@0.733968:0.652865:0.771103:0.652865:0.771103:0.640590:0.733968:0.640590:0.005668:0.008702:0.010807:0.008702:0.003257
1997;277:1205-1213.:@0.771092:0.652865:0.882487:0.652865:0.882487:0.640590:0.771092:0.640590:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006515:0.003257
20. Grozinsky-Glasberg s, Fraser A, Nahshoni E, :@0.519032:0.663767:0.793481:0.663767:0.793481:0.651491:0.519032:0.651491:0.006515:0.006515:0.003257:0.008914:0.010254:0.003540:0.007702:0.004998:0.002352:0.007173:0.004563:0.005903:0.006303:0.003904:0.010254:0.002352:0.008032:0.004563:0.008020:0.007644:0.003540:0.007914:0.004092:0.005856:0.003257:0.004092:0.005703:0.003540:0.008032:0.004563:0.007644:0.003540:0.004092:0.008702:0.003257:0.004092:0.008702:0.008032:0.007173:0.004563:0.007173:0.007702:0.007173:0.002352:0.004092:0.006303:0.003257:0.003257
et al:@0.794316:0.663767:0.820422:0.663767:0.820422:0.651491:0.794316:0.651491:0.007644:0.003986:0.004092:0.008032:0.002352
. Thyroxine-triiodo-:@0.820422:0.663767:0.923797:0.663767:0.923797:0.651491:0.820422:0.651491:0.003257:0.004092:0.005009:0.007173:0.006303:0.003540:0.007702:0.005644:0.002352:0.007173:0.007644:0.003904:0.003986:0.003540:0.002352:0.002352:0.007702:0.008055:0.007691:0.003904
thyronine combination therapy versus thyroxine monotherapy for:@0.544232:0.674668:0.923785:0.674668:0.923785:0.662393:0.544232:0.662393:0.003986:0.007173:0.006303:0.003540:0.007702:0.007173:0.002352:0.007173:0.007644:0.004986:0.007608:0.007702:0.011030:0.008020:0.002352:0.007173:0.008032:0.003986:0.002352:0.007702:0.007173:0.004998:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.004998:0.006515:0.007644:0.003540:0.004563:0.007150:0.004563:0.004998:0.003986:0.007173:0.006303:0.003540:0.007702:0.005644:0.002352:0.007173:0.007644:0.004986:0.011030:0.007702:0.007173:0.007702:0.003986:0.007173:0.007644:0.003540:0.008032:0.008020:0.006303:0.004986:0.003692:0.007702:0.003540
clinical hypothyroidism: Meta-analysis of randomized controlled tri-:@0.544232:0.685569:0.923809:0.685569:0.923809:0.673294:0.544232:0.673294:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003445:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.003434:0.010807:0.007644:0.003986:0.008032:0.003904:0.008032:0.007173:0.008032:0.002352:0.006303:0.004563:0.002352:0.004563:0.003445:0.007702:0.003692:0.003434:0.003540:0.008032:0.007173:0.008055:0.007702:0.011030:0.002352:0.004998:0.007644:0.008055:0.003434:0.007608:0.007702:0.007173:0.003986:0.003540:0.007702:0.002352:0.002352:0.007644:0.008055:0.003434:0.003986:0.003540:0.002352:0.003904
als. :@0.544232:0.696471:0.565693:0.696471:0.565693:0.684196:0.544232:0.684196:0.008032:0.002352:0.004563:0.003257:0.003257
J Clin Endocrinol Metab. :@0.565693:0.696471:0.707521:0.696471:0.707521:0.684196:0.565693:0.684196:0.005668:0.003257:0.009560:0.002352:0.002352:0.007173:0.003257:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.003257:0.010807:0.007644:0.003986:0.008032:0.008020:0.003246:0.003257
2006; 91(7):2592-2599.:@0.707521:0.696471:0.830887:0.696471:0.830887:0.684196:0.707521:0.684196:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.006550:0.003257
21.  surks MI, Ortiz E, Daniels GH, :@0.519032:0.707372:0.703229:0.707372:0.703229:0.695097:0.519032:0.695097:0.006515:0.006515:0.003257:0.003257:0.005656:0.005856:0.007150:0.003540:0.005903:0.004563:0.002987:0.010807:0.002658:0.003257:0.002987:0.010219:0.003540:0.003986:0.002352:0.004998:0.002987:0.006303:0.003257:0.002987:0.008749:0.008032:0.007173:0.002352:0.007644:0.002352:0.004563:0.002999:0.010254:0.008032:0.003257:-0.300694
et al:@0.702958:0.707372:0.727959:0.707372:0.727959:0.695097:0.702958:0.695097:0.007644:0.003986:0.002987:0.008032:0.002352
. subclinical thyroid disease: scien-:@0.727959:0.707372:0.923785:0.707372:0.923785:0.695097:0.727959:0.695097:0.003257:0.002987:0.005856:0.007150:0.008020:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.002999:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002987:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.002987:0.005856:0.007608:0.002352:0.007644:0.007173:0.003904
tific review and guidelines for diagnosis and management. :@0.544232:0.718274:0.886050:0.718274:0.886050:0.705999:0.544232:0.705999:0.003986:0.002352:0.002863:0.002863:0.007608:0.003881:0.003540:0.007644:0.006515:0.002352:0.007644:0.009772:0.003881:0.008032:0.007173:0.008055:0.003881:0.007914:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.003881:0.003692:0.007702:0.003540:0.003869:0.008055:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.002352:0.004563:0.003881:0.008032:0.007173:0.008055:0.003881:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257:0.003257
JAMA. :@0.886673:0.718274:0.927066:0.718274:0.927066:0.705999:0.886673:0.705999:0.005668:0.008702:0.010807:0.008702:0.003257:0.003257
2004;291(2):228-238. :@0.544232:0.729175:0.661048:0.729175:0.661048:0.716900:0.544232:0.716900:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257:0.003257
22. Biondi B, Cooper DS. The clinical significance of subclinical thyroid :@0.519032:0.740077:0.927055:0.740077:0.927055:0.727801:0.519032:0.727801:0.006515:0.006515:0.003257:0.008914:0.006750:0.002352:0.007702:0.007173:0.008055:0.002352:0.003928:0.006750:0.003257:0.003916:0.009560:0.007702:0.007702:0.008020:0.007644:0.003540:0.003916:0.008749:0.005856:0.003257:0.003916:0.005009:0.007173:0.007644:0.003916:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003928:0.004563:0.002352:0.007914:0.007173:0.002352:0.002863:0.002863:0.007608:0.008032:0.007173:0.007608:0.007644:0.003916:0.007702:0.003692:0.003916:0.004563:0.007150:0.008020:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003928:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:-0.567347
dysfunction. :@0.544232:0.750978:0.616504:0.750978:0.616504:0.738703:0.544232:0.738703:0.008055:0.006303:0.004563:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.003257
Endocr Rev.:@0.616504:0.750978:0.684696:0.750978:0.684696:0.738703:0.616504:0.738703:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.003257:0.007138:0.007644:0.006515:0.003257
 2008; 29(1):76-131.:@0.684685:0.750978:0.791729:0.750978:0.791729:0.738703:0.684685:0.738703:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
23. Ross  sD.  subclinical  hypothyroidism. Available  at  www.uptodate-:@0.519032:0.761880:0.923785:0.761880:0.923785:0.749604:0.519032:0.749604:0.006515:0.006515:0.003257:0.008914:0.007138:0.007702:0.004563:0.004563:0.003257:0.001787:0.005856:0.008749:0.003257:0.003257:0.001787:0.005856:0.007150:0.008020:0.007608:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003257:0.001799:0.007173:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003257:0.005045:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.003257:0.001799:0.008032:0.003986:0.003257:0.001787:0.009772:0.009772:0.009772:0.003257:0.007150:0.008020:0.003986:0.007702:0.008055:0.008032:0.003986:0.007644:-0.591982
online.com. Accessed March 2012:@0.544232:0.772781:0.740847:0.772781:0.740847:0.760506:0.544232:0.760506:0.007702:0.007173:0.002352:0.002352:0.007173:0.007644:0.003257:0.007608:0.007702:0.011018:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.010807:0.008032:0.003540:0.007608:0.007173:0.003257:0.006515:0.006515:0.006515:0.006515
24. Us preventive services Task Force. screening for thyroid disease: Rec-:@0.519032:0.783683:0.923821:0.783683:0.923821:0.771407:0.519032:0.771407:0.006632:0.006632:0.003257:0.008678:0.007585:0.005739:0.002787:0.006844:0.003422:0.007526:0.006397:0.007526:0.007056:0.003869:0.002234:0.006397:0.007526:0.002787:0.005739:0.007526:0.003422:0.006397:0.002234:0.007491:0.007526:0.004445:0.002787:0.004892:0.007914:0.004445:0.005786:0.002787:0.005586:0.007585:0.003422:0.007491:0.007526:0.003140:0.002787:0.005739:0.007491:0.003422:0.007526:0.007526:0.007056:0.002234:0.007056:0.007796:0.002787:0.003575:0.007585:0.003422:0.002787:0.003869:0.007056:0.006185:0.003422:0.007585:0.002234:0.007937:0.002787:0.007937:0.002234:0.004445:0.007526:0.007914:0.004445:0.007526:0.003140:0.002787:0.007020:0.007526:0.007491:0.003904
ommendation statement. :@0.544232:0.794584:0.691340:0.794584:0.691340:0.782309:0.544232:0.782309:0.007585:0.010913:0.010913:0.007526:0.007056:0.007937:0.007914:0.003869:0.002234:0.007585:0.007056:0.003140:0.004445:0.003869:0.007914:0.003869:0.007526:0.010913:0.007526:0.007056:0.003869:0.003140:0.003257
Ann Intern Med.:@0.691223:0.794584:0.781075:0.794584:0.781075:0.782309:0.691223:0.782309:0.008584:0.007056:0.007056:0.003140:0.002540:0.007056:0.003869:0.007526:0.003422:0.007056:0.003140:0.010689:0.007526:0.007937:0.003257
 2004 Jan;140(2):125-7.:@0.780958:0.794584:0.906288:0.794584:0.906288:0.782309:0.780958:0.782309:0.003140:0.006397:0.006397:0.006397:0.006397:0.003140:0.005550:0.007914:0.007056:0.003140:0.006397:0.006397:0.006397:0.004222:0.006397:0.004222:0.003140:0.006397:0.006397:0.006397:0.003786:0.006397:0.003257
25. UK  Guidelines for  the  use  of  thyroid  function  tests.  Association  of:@0.519032:0.805486:0.923797:0.805486:0.923797:0.793210:0.519032:0.793210:0.006515:0.006515:0.003257:0.008914:0.007702:0.006950:0.003257:0.001823:0.010254:0.007150:0.002352:0.008055:0.007644:0.002352:0.002352:0.007173:0.007644:0.004563:0.005092:0.003692:0.007702:0.003540:0.003257:0.001823:0.003986:0.007173:0.007644:0.003257:0.001823:0.007150:0.004563:0.007644:0.003257:0.001823:0.007702:0.003692:0.003257:0.001823:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003257:0.001823:0.003692:0.007150:0.007173:0.007608:0.003986:0.002352:0.007702:0.007173:0.003257:0.001823:0.003986:0.007644:0.004563:0.003986:0.004563:0.003257:0.003257:0.001823:0.008702:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.001823:0.007702:-0.649309
Clinical Biochemistry, British Thyroid Association, British Thyroid Foun-:@0.544232:0.816387:0.923797:0.816387:0.923797:0.804112:0.544232:0.804112:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003175:0.006750:0.002352:0.007702:0.007608:0.007173:0.007644:0.011030:0.002352:0.004563:0.003986:0.003540:0.006303:0.003257:0.003175:0.006750:0.003540:0.002352:0.003986:0.002352:0.004563:0.007173:0.003175:0.005009:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003163:0.008702:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.003163:0.006750:0.003540:0.002352:0.003986:0.002352:0.004563:0.007173:0.003175:0.005009:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003163:0.005703:0.007702:0.007150:0.007185:0.003904
dation. Available at www.british-thyroid-association.org/ TFT_guide-:@0.544232:0.827289:0.923797:0.827289:0.923797:0.815013:0.544232:0.815013:0.008055:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.002822:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.002834:0.008032:0.003986:0.002822:0.009772:0.009772:0.009772:0.003257:0.008020:0.003540:0.002352:0.003986:0.002352:0.004563:0.007173:0.003904:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.003904:0.008032:0.004563:0.004563:0.007702:0.007608:0.002352:0.008032:0.003986:0.002352:0.007702:0.007173:0.003257:0.007702:0.003540:0.007914:0.005139:0.002810:0.005009:0.005703:0.005009:0.005880:0.007914:0.007150:0.002352:0.008055:0.007632:0.003904
line_final_version_July_2006.pdf July 2006:@0.544232:0.838190:0.774643:0.838190:0.774643:0.825915:0.544232:0.825915:0.002352:0.002352:0.007173:0.007644:0.005880:0.002863:0.002863:0.007173:0.008032:0.002352:0.005880:0.006515:0.007644:0.003540:0.004563:0.002352:0.007702:0.007173:0.005880:0.005668:0.007150:0.002352:0.006303:0.005880:0.006515:0.006515:0.006515:0.006515:0.003257:0.008020:0.008055:0.003692:0.003257:0.005668:0.007150:0.002352:0.006303:0.003257:0.006515:0.006515:0.006515:0.006515
. Accessed April 2012.:@0.774666:0.838190:0.898362:0.838190:0.898362:0.825915:0.774666:0.825915:0.003257:0.003257:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.008702:0.008020:0.003540:0.002352:0.002352:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
26. Fitzpatrick  DL,  Russell MA.  Diagnosis and  management  of  thyroid:@0.519032:0.849092:0.923785:0.849092:0.923785:0.836816:0.519032:0.836816:0.006515:0.006515:0.003257:0.008914:0.005703:0.002352:0.003986:0.004998:0.008020:0.008032:0.003986:0.003540:0.002352:0.007608:0.005903:0.003257:0.001776:0.008749:0.005433:0.003257:0.003257:0.001776:0.007138:0.007150:0.004563:0.004563:0.007644:0.002352:0.002352:0.005045:0.010807:0.008702:0.003257:0.003257:0.001776:0.008749:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.002352:0.004563:0.005045:0.008032:0.007173:0.008055:0.003257:0.001776:0.011030:0.008032:0.007173:0.008032:0.007914:0.007644:0.011030:0.007644:0.007173:0.003986:0.003257:0.001776:0.007702:0.003692:0.003257:0.001776:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:-0.702037
disease in pregnancy. :@0.544232:0.859993:0.673043:0.859993:0.673043:0.847718:0.544232:0.847718:0.008055:0.002352:0.004563:0.007644:0.008032:0.004563:0.007644:0.003257:0.002352:0.007173:0.003257:0.008020:0.003540:0.007644:0.007914:0.007173:0.008032:0.007173:0.007608:0.006303:0.003257:0.003257
Obstet Gynecol Clin N Am.:@0.673043:0.859993:0.826654:0.859993:0.826654:0.847718:0.673043:0.847718:0.010219:0.008020:0.004563:0.003986:0.007644:0.003986:0.003257:0.010254:0.006303:0.007173:0.007644:0.007608:0.007702:0.002352:0.003257:0.009560:0.002352:0.002352:0.007173:0.003257:0.008702:0.003257:0.008702:0.011030:0.003257
 2010;37:173-193.:@0.826642:0.859993:0.921751:0.859993:0.921751:0.847718:0.826642:0.847718:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
27. Ross sD. Hypothyroidism during pregnancy: Clinical manifestations,:@0.519044:0.870894:0.923809:0.870894:0.923809:0.858619:0.519044:0.858619:0.006515:0.006515:0.003257:0.008914:0.007138:0.007702:0.004563:0.004563:0.003410:0.005856:0.008749:0.003257:0.003410:0.008032:0.006303:0.008020:0.007702:0.003986:0.007173:0.006303:0.003540:0.007702:0.002352:0.008055:0.002352:0.004563:0.011030:0.003410:0.008055:0.007150:0.003540:0.002352:0.007173:0.007914:0.003410:0.008020:0.003540:0.007644:0.007914:0.007173:0.008032:0.007173:0.007608:0.006303:0.003257:0.003398:0.009560:0.002352:0.002352:0.007173:0.002352:0.007608:0.008032:0.002352:0.003422:0.011030:0.008032:0.007173:0.002352:0.003692:0.007644:0.004563:0.003986:0.008032:0.003986:0.002352:0.007702:0.007173:0.004563:-0.735410
diagnosis and treatment. Available at www.uptodateonline.com. :@0.544244:0.881796:0.927066:0.881796:0.927066:0.869521:0.544244:0.869521:0.008055:0.002352:0.008032:0.007914:0.007173:0.007702:0.004563:0.002352:0.004563:0.004586:0.008032:0.007173:0.008055:0.004586:0.003986:0.003540:0.007644:0.008032:0.003986:0.011030:0.007644:0.007173:0.003986:0.003257:0.004574:0.008702:0.006515:0.008032:0.002352:0.002352:0.008032:0.008020:0.002352:0.007644:0.004586:0.008032:0.003986:0.004586:0.009772:0.009772:0.009772:0.003257:0.007150:0.008020:0.003986:0.007702:0.008055:0.008032:0.003986:0.007644:0.007702:0.007173:0.002352:0.002352:0.007173:0.007644:0.003257:0.007608:0.007702:0.011018:0.003257:0.003257
Accessed April 2012.:@0.544244:0.892697:0.661425:0.892697:0.661425:0.880422:0.544244:0.880422:0.008702:0.007608:0.007608:0.007644:0.004563:0.004563:0.007644:0.008055:0.003257:0.008702:0.008020:0.003540:0.002352:0.002352:0.003257:0.006515:0.006515:0.006515:0.006515:0.003257
28. Wartofsky L. Myxoedema coma. :@0.519044:0.903599:0.733474:0.903599:0.733474:0.891323:0.519044:0.891323:0.006515:0.006515:0.003257:0.008914:0.011289:0.008032:0.003540:0.003986:0.007702:0.003692:0.004563:0.005903:0.006303:0.003928:0.005433:0.003257:0.003928:0.010807:0.006303:0.005644:0.007702:0.007644:0.008055:0.007644:0.011030:0.008032:0.003928:0.007608:0.007702:0.011030:0.008032:0.003257:-0.587902
Endocrinol Metab Clin North Am.:@0.734144:0.903599:0.923821:0.903599:0.923821:0.891323:0.734144:0.891323:0.006303:0.007173:0.008055:0.007702:0.007608:0.003540:0.002352:0.007173:0.007702:0.002352:0.003928:0.010807:0.007644:0.003986:0.008032:0.008020:0.003928:0.009560:0.002352:0.002352:0.007173:0.003928:0.008702:0.007702:0.003540:0.003986:0.007173:0.003916:0.008702:0.011030:0.003257
2006;35(4):687-698.:@0.544244:0.914500:0.651288:0.914500:0.651288:0.902225:0.544244:0.902225:0.006515:0.006515:0.006515:0.006515:0.003257:0.006515:0.006515:0.004339:0.006515:0.004339:0.003257:0.006515:0.006515:0.006515:0.003904:0.006515:0.006515:0.006515:0.003257
table 4. risk factors for thyroid disease:@0.077030:0.088780:0.357640:0.088780:0.357640:0.072281:0.077030:0.072281:0.006350:0.009979:0.009979:0.003629:0.009676:0.004233:0.008467:0.004233:0.004233:0.008769:0.003629:0.006652:0.008769:0.004233:0.004233:0.009979:0.009676:0.004536:0.009676:0.004838:0.006652:0.004233:0.004233:0.009676:0.004838:0.004233:0.004536:0.009071:0.008769:0.004838:0.009676:0.003629:0.009979:0.004233:0.009979:0.003629:0.006652:0.009676:0.009979:0.006652:0.009676
personal history of thyroid disease:@0.082070:0.107628:0.299179:0.107628:0.299179:0.093599:0.082070:0.093599:0.007956:0.008735:0.004045:0.005214:0.008803:0.008198:0.009179:0.002688:0.003723:0.008198:0.002688:0.005214:0.004556:0.008803:0.004045:0.007203:0.003723:0.008803:0.004220:0.003723:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
• Previous radio-iodine treatment:@0.437952:0.107628:0.657910:0.107628:0.657910:0.093599:0.437952:0.093599:0.008144:0.007445:0.007956:0.004045:0.008735:0.007445:0.002688:0.008803:0.008171:0.005214:0.003723:0.004045:0.009179:0.009206:0.002688:0.008803:0.004462:0.002688:0.008803:0.009206:0.002688:0.008198:0.008735:0.003723:0.004556:0.004045:0.008735:0.009179:0.004556:0.012606:0.008735:0.008198:0.004556
• Previous subtotal thyroidectomy:@0.438799:0.120457:0.662520:0.120457:0.662520:0.106428:0.438799:0.106428:0.008144:0.007445:0.007956:0.004045:0.008735:0.007445:0.002688:0.008803:0.008171:0.005214:0.003723:0.005214:0.008171:0.009165:0.004556:0.008803:0.004556:0.009179:0.002688:0.003723:0.004556:0.008198:0.007203:0.004045:0.008803:0.002688:0.009206:0.008735:0.008695:0.004556:0.008803:0.012606:0.007203
Medical disorders:@0.082070:0.135851:0.196491:0.135851:0.196491:0.121822:0.082070:0.121822:0.012351:0.008735:0.009206:0.002688:0.008695:0.009179:0.002688:0.003723:0.009206:0.002688:0.005214:0.008803:0.004045:0.009206:0.008735:0.004045:0.005214
• Past history of neck irradiation:@0.438799:0.135851:0.647562:0.135851:0.647562:0.121822:0.438799:0.121822:0.008144:0.007445:0.007956:0.009179:0.005214:0.004556:0.003723:0.008198:0.002688:0.005214:0.004556:0.008803:0.004045:0.007203:0.003723:0.008803:0.004220:0.003723:0.008198:0.008735:0.008695:0.006746:0.003723:0.002688:0.004045:0.004045:0.009179:0.009206:0.002688:0.009179:0.004556:0.002688:0.008803:0.008198
• Patients with Down’s syndrome or Turner’s syndrome:@0.438799:0.148679:0.792235:0.148679:0.792235:0.134650:0.438799:0.134650:0.008144:0.007445:0.007956:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.005214:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.009999:0.008803:0.011168:0.008198:0.004717:0.005214:0.003723:0.005214:0.007203:0.008198:0.009206:0.004045:0.008803:0.012606:0.008735:0.003723:0.008803:0.004045:0.003723:0.005725:0.008171:0.004045:0.008198:0.008735:0.004045:0.004717:0.005214:0.003723:0.005214:0.007203:0.008198:0.009206:0.004045:0.008803:0.012606:0.008735
Diagnosis of auto-immune disease:@0.082070:0.164073:0.304434:0.164073:0.304434:0.150044:0.082070:0.150044:0.009999:0.002688:0.009179:0.009045:0.008198:0.008803:0.005214:0.002688:0.005214:0.003723:0.008803:0.004220:0.003723:0.009179:0.008171:0.004556:0.008803:0.004462:0.002688:0.012606:0.012606:0.008171:0.008198:0.008735:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
• Patients with type 1 diabetes:@0.438799:0.164073:0.641555:0.164073:0.641555:0.150044:0.438799:0.150044:0.008144:0.007445:0.007956:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.005214:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.004556:0.007203:0.009165:0.008735:0.003723:0.007445:0.003723:0.009206:0.002688:0.009179:0.009165:0.008735:0.004556:0.008735:0.005214
• Patients with auto-immune Addison’s disease:@0.438799:0.176901:0.747308:0.176901:0.747308:0.162872:0.438799:0.162872:0.008144:0.007445:0.007956:0.009179:0.004556:0.002688:0.008735:0.008198:0.004556:0.005214:0.003723:0.011168:0.002688:0.004556:0.008198:0.003723:0.009179:0.008171:0.004556:0.008803:0.004462:0.002688:0.012606:0.012606:0.008171:0.008198:0.008735:0.003723:0.009945:0.009206:0.009206:0.002688:0.005214:0.008803:0.008198:0.004717:0.005214:0.003723:0.009206:0.002688:0.005214:0.008735:0.009179:0.005214:0.008735
Drug therapy:@0.082070:0.192295:0.168134:0.192295:0.168134:0.178266:0.082070:0.178266:0.009999:0.004045:0.008171:0.009045:0.003723:0.004556:0.008198:0.008735:0.004045:0.009179:0.009165:0.007203
• Lithium:@0.438799:0.192295:0.499503:0.192295:0.499503:0.178266:0.438799:0.178266:0.008144:0.007445:0.006209:0.002688:0.004556:0.008198:0.002688:0.008171:0.012606
• Amiodarone:@0.438799:0.205123:0.536595:0.205123:0.536595:0.191094:0.438799:0.191094:0.008144:0.007445:0.009945:0.012606:0.002688:0.008803:0.009206:0.009179:0.004045:0.008803:0.008198:0.008735